
Health Mart is owned by McKesson Corporation (NYSE: MCK), a publicly traded American healthcare company headquartered in Irving, Texas. Founded in 1985, Health Mart operates as a wholly-owned subsidiary of McKesson, functioning as an independent pharmacy franchise network with over 4,500 member pharmacies across all 50 states. McKesson acquired the franchise in 1996 through its purchase of FoxMeyer. Health Mart ranked highest among brick-and-mortar chain drug store pharmacies in J.D. Power's 2025 U.S. Pharmacy Study.
Parent Company
Acquired
1996
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Health Mart | McKesson Corporation | Wholly owned |
Health Mart was founded in 1985 by FoxMeyer Corporation as an independent pharmacy franchise network. The concept was to give independent pharmacists a collective brand, purchasing power, and support services to compete with large chain pharmacies like CVS and Walgreens. At the time, independent pharmacies were losing market share to national chains, and franchise networks offered a way to preserve local ownership while gaining economies of scale.
In October 1996, McKesson Corporation acquired FoxMeyer Corporation in a deal valued at approximately $1.2 billion. FoxMeyer had filed for Chapter 11 bankruptcy protection in August 1996 after suffering significant losses from a failed contract to supply pharmaceuticals to the University of Texas System. McKesson purchased FoxMeyer's wholesale distribution business, including the Health Mart franchise network, which had approximately 1,200 member pharmacies at the time.
Under McKesson's ownership, Health Mart grew steadily. By 2005, the network had reached approximately 2,000 pharmacies. By 2015, it had grown to over 3,500. As of 2025, Health Mart has over 4,500 member pharmacies across all 50 states, making it one of the largest independent pharmacy franchise networks in the United States.
The growth of Health Mart reflects broader trends in the pharmacy industry. Independent pharmacies have faced pressure from chain pharmacies, mail-order services, and pharmacy benefit managers (PBMs). Franchise networks like Health Mart provide independent pharmacists with group purchasing power, technology platforms, marketing support, and clinical service tools that would be difficult to access individually.
In 2025, Health Mart ranked highest among brick-and-mortar chain drug store pharmacies in the J.D. Power U.S. Pharmacy Study. This was a significant achievement for a franchise network competing against vertically integrated chains like CVS Health and Walgreens. The ranking reflected customer satisfaction with pharmacists, store experience, and cost competitiveness.
Health Mart holds an annual conference called ideaShare, which brings together thousands of independent pharmacy owners. The 2025 ideaShare conference was held in Las Vegas. At the conference, Health Mart presents the Pharmacy of the Year award to recognize outstanding franchise members. In 2025, Dave's Pharmacy in Alliance, Nebraska, received the award for its innovative clinical services and community health programs.
What does McKesson do?
McKesson distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and Canada. The company also operates the US Oncology Network, distributes medical-surgical supplies, and provides technology solutions to biopharma manufacturers through its Prescription Technology Solutions segment.
Is McKesson publicly traded?
Yes. McKesson Corporation trades on the New York Stock Exchange under ticker symbol MCK. The company has no controlling shareholder, with ownership distributed among institutional investors including Vanguard Group and BlackRock.
What is McKesson's annual revenue?
McKesson reported consolidated revenue of $403.4 billion for fiscal year 2026, which ended March 31, 2026. This represented a 12% increase from $359.1 billion in fiscal year 2025. Adjusted earnings per diluted share were $39.11, up 18% year over year.
Who is McKesson's CEO?
Brian Tyler has served as Chief Executive Officer of McKesson since April 2019, succeeding John Hammergren. Tyler has led the company's strategic focus on oncology and biopharma services as higher-growth businesses within the healthcare distribution ecosystem.
When was McKesson founded?
McKesson was founded in 1833 by John McKesson and Charles Olcott in New York City as Olcott & McKesson, making it one of the oldest continuously operating companies in the United States.
What is McKesson's role in the opioid settlement?
McKesson, along with Cencora and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. McKesson's share of the settlement is approximately $7.9 billion, to be paid over 18 years.
What is McKesson's largest customer?
CVS Health Corporation is McKesson's largest customer, accounting for approximately 24% of total consolidated revenue in fiscal year 2026. The pharmaceutical distribution partnership between McKesson and CVS extends to June 2027. McKesson's ten largest customers collectively account for approximately 73% of consolidated revenue.
Health Mart's sustainability practices are governed by McKesson Corporation's corporate environmental framework. McKesson has set portfolio-wide targets that apply to its operations, including distribution centers that supply Health Mart pharmacies.
McKesson has committed to science-based emissions reduction targets aligned with limiting global warming to 1.5 degrees Celsius. In fiscal 2025, McKesson achieved its goal of having 70% of suppliers set SBTi-approved greenhouse gas reduction targets. The company has invested in Virtual Power Purchase Agreements, including becoming a virtual customer of Recurrent Energy's 100-MWac Liberty Solar plant, which reduces annual carbon emissions by approximately 182,000 metric tons.
McKesson has implemented reusable cold chain packaging systems for transporting temperature-sensitive pharmaceutical products. The reusable system includes an outer shell, inner lining, and phase change material designed to maintain 2-8 degrees Celsius for 24 hours, reducing waste compared to single-use packaging.
No brand-specific sustainability certifications apply to Health Mart, as the franchise network consists of independently owned pharmacies that manage their own facility operations. McKesson's corporate sustainability targets apply to its distribution centers and corporate operations, not directly to individual Health Mart pharmacy locations.
On ethics, Health Mart pharmacies operate under McKesson's corporate compliance framework, which includes fair business practices, patient privacy protection under HIPAA, and regulatory compliance with DEA requirements for controlled substances. Individual pharmacy owners are responsible for maintaining compliance with state board of pharmacy regulations.
J.D. Power 2025 U.S. Pharmacy Study: Health Mart ranked highest among brick-and-mortar chain drug store pharmacies in the J.D. Power 2025 U.S. Pharmacy Study. This study measures customer satisfaction across multiple factors including pharmacists, store experience, cost, and merchandise. Health Mart's ranking reflected the personalized service and community focus of its independent pharmacy model.
Health Mart Pharmacy of the Year: Health Mart presents an annual Pharmacy of the Year award at its ideaShare conference. In 2025, Dave's Pharmacy in Alliance, Nebraska, received the award for innovative clinical services, including comprehensive medication therapy management and community health programs. The award recognizes franchise members who demonstrate excellence in independent pharmacy practice.
NCPA Recognition: Health Mart franchise members have received recognition from the National Community Pharmacists Association (NCPA) for leadership in community pharmacy practice. These awards highlight the network's commitment to community health and professional excellence.
McKesson Opioid Settlement (2022): McKesson Corporation, Health Mart's parent company, agreed to a $5.9 billion settlement in 2022 to resolve opioid-related claims brought by states, local governments, and Native American tribes. The settlement addressed allegations that McKesson failed to adequately monitor and report suspicious orders of prescription opioids distributed through its network. The settlement is being paid over 18 years. While Health Mart pharmacies were not the primary focus of the opioid distribution allegations (which centered on McKesson's wholesale distribution to pharmacies, not its franchise network), the settlement affects the parent company that owns and operates the Health Mart brand. McKesson has since implemented enhanced monitoring and compliance systems for controlled substance distribution.
PBM Reimbursement Pressures: Independent pharmacies, including Health Mart members, have faced declining reimbursement rates from pharmacy benefit managers. The Federal Trade Commission has investigated PBM practices, and multiple states have passed legislation to regulate PBM reimbursement. Health Mart pharmacies have been affected by these pressures, with some members closing due to unsustainable margins. Health Mart provides group contracting support to help members negotiate better reimbursement terms, but the structural challenge of PBM control over prescription drug pricing remains ongoing.
Independent Pharmacy Closures: The independent pharmacy segment has experienced a net decline in recent years. According to the National Community Pharmacists Association, independent pharmacies closed at a rate of approximately 2-3 per week in 2024. Health Mart has not been immune to this trend, though its franchise support services help members remain competitive. Rural communities have been disproportionately affected by pharmacy closures, creating pharmacy deserts where residents must travel significant distances for prescription medications.
No direct competitors found in the same category. This could be because Health Martoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by McKesson Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Health Mart which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Health Mart which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Bausch + Lomb Corporation
Global eye health company and contact lens manufacturer founded in 1853, known for ULTRA, Biotrue One Day, and INFUSE lens lines. Public on NYSE and TSX under BLCO.
Bausch + Lomb operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
Retavase is privately owned, unlike Health Mart which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.